Fibrotech Therapeutics
Wonga Park
About Fibrotech Therapeutics
Fibrotech Therapeutics develops and offers novel drug candidates for the treatment of fibrosis in chronic conditions. It develops drugs for kidney diseases, diabetics, heart failure, pulmonary fibrosis, and arthritis. Founded in 2006, Fibrotech Therapeutics is based in Wonga Park, Australia.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $5.0M
- Funding stage: M&A
- Last round: Series A (Dec 2008)
- Website: fibrotech.com.au
Industries & Categories
Education, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/fibrotech-therapeutics-1019988 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.